MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioadaptives Inc (OP:BDPT)

0.0182 UNCHANGED
Streaming Delayed Price Updated: 3:03 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 0.0182
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0182
Today's Range 0.0182 - 0.0182
52wk Range 0.0132 - 0.1500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – BioAdaptives, Inc. (OTCMKTS: BDPT) Launches MyndMed Cognitive-Support Supplement Following Successful Testing and Strong Early Demand
Via Investor Brand Network
BioMedNewsBreaks — BioAdaptives, Inc. (OTCMKTS: BDPT) Receives WADA-Compliant Certification for MyndMed(TM) From TruShield(TM)
Via Investor Brand Network

Performance

YTD
-17.3%
-17.3%
1 Month
-33.8%
-33.8%
3 Month
-41.3%
-41.3%
6 Month
-69.2%
-69.2%
1 Year
-84.7%
-84.7%

More News

Read More
InvestorNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) Prepares for National Launch of NeuroRush(TM) Nootropic in Late Summer 2025
Via Investor Brand Network
InvestorNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) to Launch Pawpa(TM) Regen Nationwide as Stem Cell-Based Canine Supplement Gains Momentum
Via Investor Brand Network
News headline image
BioAdaptives Announces National Launch of Pawpa™ Regen
From BioAdaptives Inc.
Via GlobeNewswire
InvestorNewsBreaks – Bioadaptives Inc (BDPT) Showcases Breakthrough Stem Cell Benefits in Regen Dog Chews
Via Investor Brand Network
News headline image
InvestorNewsBreaks – Bioadaptives Inc (BDPT) Completes Successful Dosage Trials for Zeranovia™ Weight Loss Product
Via Investor Brand Network
BioMedNewsBreaks – BioAdaptives Inc. (BDPT) Announces Board Appointment of UFC Senior Executive Reed Harris
Via Investor Brand Network
BioMedNewsBreaks — BioAdaptives Inc. (BDPT) Announces Board Appointment of Visionary Leader Mark Frissora
Via Investor Brand Network
BioMedNewsBreaks — BioAdaptives Inc. (BDPT) Announces Dividend for Common Stock Shareholders
Via Investor Brand Network
BioMedNewsBreaks – BioAdaptives Inc. (BDPT) Launches Xcellara(TM) — an Innovative Supplement That Harnesses Nature for Optimal Health
Via Investor Brand Network
InvestorNewsBreaks — BioAdaptives Inc. (BDPT) Announces One-for-One Stock Dividend
Via Investor Brand Network
BioMedNewsBreaks — BioAdaptives Inc. (BDPT) to Proceed with Human Clinical Trial for Zeranovia(TM)
Via Investor Brand Network
BioMedNewsBreaks – BioAdaptives Inc. (BDPT) Unveils New Suite of Next-Gen Nutritional Products
Via Investor Brand Network
InvestorNewsBreaks – BioAdaptives, Inc. (BDPT) Appoints Car Rental Industry Veteran to Its Board of Directors
Via Investor Brand Network
News headline image
BioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives
Via NewMediaWire
BioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives
Via TheNewswire.com
BioAdaptives, Inc. Announces NaturaComplete, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
Via NewMediaWire
Topics Artificial Intelligence
News headline image
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
Via NewMediaWire
Topics Artificial Intelligence
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
Via TheNewswire.com
Topics Artificial Intelligence
BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products
Via NewMediaWire
Topics Retirement
BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products
Via TheNewswire.com
Topics Retirement
News headline image
BioAdaptives Announces Signing of a New Distributors Agreement for AI Body Composition Measuring App and New Weight Management System
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
News headline image
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products
Via NewMediaWire
Topics Artificial Intelligence
News headline image
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management
Via NewMediaWire
Topics Artificial Intelligence

Frequently Asked Questions

Is Bioadaptives Inc publicly traded?
Yes, Bioadaptives Inc is publicly traded.
What exchange does Bioadaptives Inc trade on?
Bioadaptives Inc trades on the OTC Traded
What is the ticker symbol for Bioadaptives Inc?
The ticker symbol for Bioadaptives Inc is BDPT on the OTC Traded
What is the current price of Bioadaptives Inc?
The current price of Bioadaptives Inc is 0.0182
When was Bioadaptives Inc last traded?
The last trade of Bioadaptives Inc was at 01/08/26 03:03 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story